CR20150059A - SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B - Google Patents

SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B

Info

Publication number
CR20150059A
CR20150059A CR20150059A CR20150059A CR20150059A CR 20150059 A CR20150059 A CR 20150059A CR 20150059 A CR20150059 A CR 20150059A CR 20150059 A CR20150059 A CR 20150059A CR 20150059 A CR20150059 A CR 20150059A
Authority
CR
Costa Rica
Prior art keywords
hepatitis
sulfamoilarilamidas
medicines
treatment
hbv
Prior art date
Application number
CR20150059A
Other languages
Spanish (es)
Inventor
Stefaan Julien Last
Pierre Jean-Marie Bernard Raboisson
Geert Rombouts
Koen Vandyck
Wim Gaston Verschueren
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/067829 external-priority patent/WO2014033176A1/en
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Publication of CR20150059A publication Critical patent/CR20150059A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Inhibidores de la replicación del virus de la hepatitis B (VHB) de la fórmula I, incluidas sus formas estereoquimicamente isoméricas y sales, hidratos y solvatos, en donde B, R1, R2 y R4 tienen el significado definido.Hepatitis B virus (HBV) replication inhibitors of the formula I, including its stereochemically isomeric forms and salts, hydrates and solvates, wherein B, R1, R2 and R4 have the definite meaning.

CR20150059A 2012-08-28 2015-02-09 SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B CR20150059A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12182076 2012-08-28
EP12185055 2012-09-19
EP12190837 2012-10-31
PCT/EP2013/067829 WO2014033176A1 (en) 2012-08-28 2013-08-28 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b

Publications (1)

Publication Number Publication Date
CR20150059A true CR20150059A (en) 2015-04-14

Family

ID=53801254

Family Applications (2)

Application Number Title Priority Date Filing Date
CR20150060A CR20150060A (en) 2012-08-28 2015-02-09 SULFAMOYLARILAMIDS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B.
CR20150059A CR20150059A (en) 2012-08-28 2015-02-09 SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CR20150060A CR20150060A (en) 2012-08-28 2015-02-09 SULFAMOYLARILAMIDS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B.

Country Status (1)

Country Link
CR (2) CR20150060A (en)

Also Published As

Publication number Publication date
CR20150060A (en) 2015-04-14

Similar Documents

Publication Publication Date Title
CR20160237A (en) DERIVATIVES OF CARBOXAMIDE AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
NI201600115A (en) SULFAMOYLPYRROLAMIDE DERIVATIVES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B.
CO2017012268A2 (en) Cyclic sulfamoylarylamide derivatives and their use as medicines for the treatment of hepatitis b
NI201500029A (en) SULFAMOYLARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B.
CR20160006A (en) PIRROLAMIDE DERIVATIVES REPLACED WITH GLIOXAMIDE AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
NI201500161A (en) SULFAMOYLPYRROLAMIDE DERIVATIVES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
CL2015002151A1 (en) Biaryl amide compounds as kinase inhibitors
CL2016000493A1 (en) Hcv polymerase inhibitors
CL2015001377A1 (en) Inhibitors of bmi-1 reverse substituted primidins
CL2015002891A1 (en) Deaza-macrocyclic purinones for the treatment of viral infections.
CL2015000942A1 (en) Compounds of substituted benzene.
CL2015001916A1 (en) Pyrimidone derivatives and their use in the treatment, improvement or prevention of a viral disease.
BR112017013491A2 (en) fused pyrimidine compounds for the treatment of hiv
CL2013002898A1 (en) Compounds derived from aryl or heteroaryl substituted benzene; pharmaceutical composition that understands them and use in the treatment of cancer.
CL2016001973A1 (en) Nucleoside derivatives substituted with 4'-difluoromethyl as inhibitors of influenza arn replication.
CL2015002897A1 (en) Bace1 inhibitors
BR112017028549A2 (en) pyrimidine derivatives as btk inhibitors and uses thereof
CL2016000597A1 (en) Derivatives of deoxino jirimicina and its methods of use.
CR20160316A (en) COMPOUNDS DERIVED FROM HYDROXIFORMAMIDE AND USES OF THE SAME
CR20150417A (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
UY35390A (en) COMPOUNDS WITH ANTI-HCV ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM